Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
- Murray, M.
- Antela, A.
- Mills, A.
- Huang, J.
- Jäger, H.
- Bernal, E.
- Lombaard, J.
- Katner, H.
- Walmsley, S.
- Khuong-Josses, M.-A.
- Hudson, K.
- Dorey, D.
- Griffith, S.
- Spreen, W.
- Vanveggel, S.
- Shaefer, M.
- Margolis, D.
- Chounta, V.
ISSN: 1573-3254, 1090-7165
Year of publication: 2020
Volume: 24
Issue: 12
Pages: 3533-3544
Type: Article